Day One Biopharmaceuticals, Inc.
DAWN2026/4/23 下市- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. 已在 2026/4/23 下市；內部人最後一份 Form 4 在 2026/4/27 申報；2026 年第 1 季末有 208 家機構在 13F 申報持有，市值合計 $18.5 億；大師中只有索羅斯基金管理持有。
持有 DAWN 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Day One Biopharmaceuticals, Inc. 5% 以上的持有人，依持股比例由大到小；變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G | 5.80%股數 585.0 萬 | +1.10 個百分點原本 4.70% | 2025/4/282 份 | 2025/7/17 | SEC |
| Glazer Capital, LLC | 13G | 5.40%股數 561.5 萬 | 新申報 | 2026/3/191 份 | 2026/3/19 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式（2024 年 12 月 18 日以前）的持有人沒有持股比例紀錄，不列在這裡；公司被收購或下市之後，持有人通常就不再申報。
13D 與 13G 申報
Day One Biopharmaceuticals, Inc. 的 44 份 Schedule 13D、13G 申報，由新到舊，包括沒有持股比例的舊格式申報。
| 申報時間（美東） | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/5/1517:02 ET | Vestal Point Capital, LP等 2 位 | 13G/A | 0.00%股數 0 | −5.10 個百分點原本 5.10%低於 5% | 2026/3/31 | SEC |
| 2026/5/1416:19 ET | Atlas Venture Fund XI, L.P.等 9 位 | 13G/A | 0.00%股數 0 | –低於 5% | 2026/3/31 | SEC |
| 2026/4/2717:55 ET | AI Day1 LLC等 4 位 | 13D/A | 0.00%股數 0 | −12.52 個百分點原本 12.52%低於 5% | 2026/4/23 | SEC |
| 2026/4/1317:06 ET | AI Day1 LLC等 4 位 | 13D/A | 12.52%股數 1,293 萬 | – | 2026/4/9 | SEC |
| 2026/4/713:22 ET | FMR LLC等 2 位 | 13G/A | 0.00%股數 2.36 萬 | −5.60 個百分點原本 5.60%低於 5% | 2026/3/31 | SEC |
| 2026/3/2617:42 ET | Vanguard Group Inc | 13G/A | 0.00%股數 0 | –低於 5% | 2026/3/13 | SEC |
| 2026/3/1916:46 ET | Glazer Capital, LLC等 2 位 | 13G | 5.40%股數 561.5 萬 | 新申報 | 2026/3/12 | SEC |
| 2026/2/1716:06 ET | Vestal Point Capital, LP等 2 位 | 13G | 5.10%股數 520.0 萬 | 新申報 | 2025/12/31 | SEC |
| 2026/2/513:20 ET | FMR LLC等 2 位 | 13G/A | 5.60%股數 571.7 萬 | −4.30 個百分點原本 9.90% | 2025/12/31 | SEC |
| 2025/11/511:30 ET | FMR LLC等 2 位 | 13G/A | 9.90%股數 1,010 萬 | −1.30 個百分點原本 11.20% | 2025/9/30 | SEC |
| 2025/8/1418:00 ET | Ra Capital Management, L.P.等 4 位 | 13G/A | 0.00%股數 0 | −5.70 個百分點原本 5.70%低於 5% | 2025/6/30 | SEC |
| 2025/8/611:56 ET | FMR LLC等 2 位 | 13G/A | 11.20%股數 1,134 萬 | −1.60 個百分點原本 12.80% | 2025/6/30 | SEC |
| 2025/7/1719:54 ET | BlackRock, Inc. | 13G | 5.80%股數 585.0 萬 | +1.10 個百分點原本 4.70% | 2025/6/30 | SEC |
| 2025/4/2817:45 ET | BlackRock, Inc. | 13G/A | 4.70%股數 481.2 萬 | –低於 5% | 2025/3/31 | SEC |
| 2025/2/1418:31 ET | Ra Capital Management, L.P.等 4 位 | 13G/A | 5.70%股數 575.6 萬 | – | 2024/12/31 | SEC |
| 2025/2/1209:28 ET | FMR LLC等 2 位 | 13G/A | 12.80%股數 1,289 萬 | – | 2024/12/31 | SEC |
| 2024/11/14 | Atlas Venture Fund XI, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2024/11/7 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/11/7 | FMR LLC | 13G舊制 | – | – | – | SEC |
| 2024/8/5 | AI Day1 LLC | 13D/A舊制 | – | – | – | SEC |
| 2024/2/14 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2024/2/13 | Vanguard Group Inc | 13G舊制 | – | 新申報 | – | SEC |
| 2024/2/9 | Atlas Venture Fund XI, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/1/2917:25 ET | BlackRock Inc. | 13G舊制 | – | 新申報 | – | SEC |
| 2023/10/20 | AI Day1 LLC | 13D/A舊制 | – | – | – | SEC |
| 2023/8/10 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/6/12 | AI Day1 LLC | 13D/A舊制 | – | – | – | SEC |
| 2023/2/14 | Atlas Venture Fund XI, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2023/2/14 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2023/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/2/3 | Takeda Pharmaceutical Co Ltd | 13G/A舊制 | – | – | – | SEC |
| 2022/11/2 | Canaan XI L.P. | 13D/A舊制 | – | – | – | SEC |
| 2022/10/19 | Canaan XI L.P. | 13D/A舊制 | – | – | – | SEC |
| 2022/9/22 | Canaan XI L.P. | 13D/A舊制 | – | – | – | SEC |
| 2022/9/19 | Canaan XI L.P. | 13D/A舊制 | – | – | – | SEC |
| 2022/9/12 | FMR LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2022/6/21 | AI Day1 LLC | 13D/A舊制 | – | – | – | SEC |
| 2022/2/11 | Atlas Venture Fund XI, L.P. | 13G舊制 | – | 新申報 | – | SEC |
| 2022/1/14 | Takeda Pharmaceutical Co Ltd | 13G舊制 | – | 新申報 | – | SEC |
| 2021/12/22 | Canaan XI L.P. | 13D/A舊制 | – | – | – | SEC |
| 2021/6/10 | Canaan XI L.P. | 13D舊制 | – | 新申報 | – | SEC |
| 2021/6/9 | AI Day1 LLC | 13D舊制 | – | 新申報 | – | SEC |
| 2021/6/7 | Ra Capital Management, L.P. | 13G舊制 | – | 新申報 | – | SEC |
Form 144：內部人預計賣出
高階主管、董事與其他關係人預計賣出 Day One Biopharmaceuticals, Inc. 股票的 39 份通知，由新到舊。
| 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/2/1718:21 ET | Jeremy Bender高階主管 · 董事 | 1.55 萬 | $17.9 萬 | 2026/2/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/2/1718:18 ET | Charles York高階主管 | 6,065 | $7.04 萬 | 2026/2/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/2/1718:13 ET | Lauren Merendino高階主管 | 5,814 | $6.74 萬 | 2026/2/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/2/1718:08 ET | Adam Dubow高階主管 | 6,395 | $7.42 萬 | 2026/2/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/1716:12 ET | Charles York高階主管 | 4,062 | $3.62 萬 | 2025/11/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/1716:12 ET | Lauren Merendino高階主管 | 3,726 | $3.32 萬 | 2025/11/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/1716:11 ET | Adam Dubow高階主管 | 4,319 | $3.85 萬 | 2025/11/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/1716:09 ET | Jeremy Bender高階主管 · 董事 | 1.59 萬 | $14.2 萬 | 2025/11/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/8/1817:33 ET | Jeremy Bender高階主管 · 董事 | 1.61 萬 | $10.9 萬 | 2025/8/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1616:09 ET | Charles York高階主管 | 4,282 | $2.68 萬 | 2025/5/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1616:09 ET | Lauren Merendino高階主管 | 3,927 | $2.46 萬 | 2025/5/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1616:08 ET | Adam Dubow高階主管 | 4,552 | $2.85 萬 | 2025/5/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1616:08 ET | Jeremy Bender高階主管 · 董事 | 1.40 萬 | $8.74 萬 | 2025/5/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/2/1818:07 ET | Adam Dubow高階主管 | 4,646 | $5.56 萬 | 2025/2/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/2/1818:04 ET | Charles York高階主管 | 4,370 | $5.23 萬 | 2025/2/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/2/1818:02 ET | Jeremy Bender高階主管 · 董事 | 1.20 萬 | $14.4 萬 | 2025/2/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/11/1816:22 ET | Samuel Blackman高階主管 | 2,206 | $2.91 萬 | 2024/11/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/11/1816:21 ET | Jeremy Bender高階主管 · 董事 | 1.06 萬 | $13.9 萬 | 2024/11/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/11/1207:49 ET | Samuel Blackman高階主管 | 5.00 萬 | $82.0 萬 | 2024/11/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/10/3116:27 ET | Samuel Blackman高階主管 | 3.00 萬 | $43.4 萬 | 2024/10/3110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/8/1617:23 ET | Jeremy Bender高階主管 · 董事 | 1.07 萬 | $15.0 萬 | 2024/8/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/8/1617:17 ET | Samuel Blackman高階主管 | 2,232 | $3.12 萬 | 2024/8/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/7/1616:32 ET | Samuel Blackman高階主管 | 8.00 萬 | $125.6 萬 | 2024/7/1610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/6/2116:14 ET | Saira Ramasastry董事 | 1.00 萬 | $13.2 萬 | 2024/6/21 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/6/1016:58 ET | Samuel Blackman高階主管 | 3.00 萬 | $38.3 萬 | 2024/6/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
只列最新的 25 份。看 DAWN 近 12 個月的全部通知